CELG
Celgene Corporation

12,318
Loading...
Loading...
News
all
press releases
Mirabella Financial Services LLP Trims Stock Position in Bristol Myers Squibb Company $BMY
Mirabella Financial Services LLP trimmed its stake in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 77.0% during the second quarter, according to its most recent 13F filing with the...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
Cresset Asset Management LLC Decreases Stock Holdings in Bristol Myers Squibb Company $BMY
Cresset Asset Management LLC decreased its stake in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 7.8% during the second quarter, according to the company in its most recent Form...
MarketBeat·6h ago
News Placeholder
Bristol Myers Squibb Company $BMY Shares Sold by Epoch Investment Partners Inc.
Epoch Investment Partners Inc. trimmed its holdings in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 3.5% in the second quarter, according to its most recent 13F filing with the Securities...
MarketBeat·6h ago
News Placeholder
Validea Detailed Fundamental Analysis - BMY
Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our Earnings Yield Investor model based on the published...
Nasdaq News: Markets·21h ago
News Placeholder
Dodge & Cox Has $390.54 Million Stake in Bristol Myers Squibb Company $BMY
Dodge & Cox reduced its stake in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 35.3% in the second quarter, according to its most recent filing with the SEC. The institutional...
MarketBeat·1d ago
News Placeholder
Dodge & Cox Has $390.54 Million Stake in Bristol Myers Squibb Company $BMY
Dodge & Cox reduced its stake in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 35.3% in the second quarter, according to its most recent filing with the SEC. The institutional...
MarketBeat·1d ago
News Placeholder
Bristol Myers Squibbs Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)
Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric...
Business Wire·2d ago
News Placeholder
Quantbot Technologies LP Takes Position in Bristol Myers Squibb Company $BMY
Quantbot Technologies LP acquired a new position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC...
MarketBeat·2d ago
News Placeholder
Invesco Ltd. Raises Stock Position in Bristol Myers Squibb Company $BMY
Invesco Ltd. boosted its position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 4.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·2d ago
News Placeholder
Wealthedge Investment Advisors LLC Buys New Holdings in Bristol Myers Squibb Company $BMY
Wealthedge Investment Advisors LLC purchased a new position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) during the second quarter, according to its most recent disclosure with...
MarketBeat·4d ago

Latest CELG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.